StockData
Standard BioTools Inc. logo

Standard BioTools Inc. (LAB) stock

LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3087% below fair value
$0.54−0.08 (-13.14%)

Close on Nov 17, 2026Market cap $211.76MP/E 2.5Yield –

Standard BioTools revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Standard BioTools's revenue for the twelve months ending Jun 30, 2026 was $84.60M, down 4.8% year over year. For fiscal 2025 it was $85.33M, down 6.2% from the year before. Over ten years it grew -2.9% a year on average. The highest annual figure on record is $138.14M in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$85.33M-6.2%
FY2024Dec 31, 2024$91.01M-14.4%
FY2023Dec 31, 2023$106.34M+8.6%
FY2022Dec 31, 2022$97.95M-25.0%
FY2021Dec 31, 2021$130.58M-5.5%
FY2020Dec 31, 2020$138.14M+17.8%
FY2019Dec 31, 2019$117.24M+3.8%
FY2018Dec 31, 2018$112.96M+10.8%
FY2017Dec 31, 2017$101.94M-2.4%
FY2016Dec 31, 2016$104.45M-8.9%
FY2015Dec 31, 2015$114.71M-1.5%
FY2014Dec 31, 2014$116.46M+63.6%
FY2013Dec 31, 2013$71.18M+36.0%
FY2012Dec 31, 2012$52.33M+22.1%
FY2011Dec 31, 2011$42.87M+27.7%
FY2010Dec 31, 2010$33.56M+32.1%
FY2009Dec 31, 2009$25.41M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$20.10M-7.6%
Q1 FY2026Mar 31, 2026$21.15M+4.6%
Q4 FY2025Dec 31, 2025$23.80M-4.0%
Q3 FY2025Sep 30, 2025$19.55M-11.5%
Q2 FY2025Jun 30, 2025$21.76M-3.2%
Q1 FY2025Mar 31, 2025$20.22M-55.6%
Q4 FY2024Dec 31, 2024$24.78M-12.1%
Q3 FY2024Sep 30, 2024$22.09M-12.9%
Q2 FY2024Jun 30, 2024$22.49M-18.7%
Q1 FY2024Mar 31, 2024$45.54M+81.3%
Q4 FY2023Dec 31, 2023$28.19M+4.3%
Q3 FY2023Sep 30, 2023$25.37M-1.1%
Q2 FY2023Jun 30, 2023$27.67M+47.3%
Q1 FY2023Mar 31, 2023$25.12M-5.2%
Q4 FY2022Dec 31, 2022$27.02M-29.4%
Q3 FY2022Sep 30, 2022$25.65M-10.0%
Q2 FY2022Jun 30, 2022$18.78M-39.5%
Q1 FY2022Mar 31, 2022$26.50M-19.2%
Q4 FY2021Dec 31, 2021$38.27M-14.2%
Q3 FY2021Sep 30, 2021$28.50M-28.5%
Q2 FY2021Jun 30, 2021$31.02M+19.0%
Q1 FY2021Mar 31, 2021$32.79M+18.7%
Q4 FY2020Dec 31, 2020$44.61M+37.5%
Q3 FY2020Sep 30, 2020$39.86M+50.4%
Q2 FY2020Jun 30, 2020$26.06M-7.6%
Q1 FY2020Mar 31, 2020$27.62M-8.3%
Q4 FY2019Dec 31, 2019$32.44M+0.4%
Q3 FY2019Sep 30, 2019$26.50M-8.5%
Q2 FY2019Jun 30, 2019$28.20M+6.7%
Q1 FY2019Mar 31, 2019$30.11M+19.3%
Q4 FY2018Dec 31, 2018$32.33M+16.5%
Q3 FY2018Sep 30, 2018$28.96M+17.0%
Q2 FY2018Jun 30, 2018$26.43M+10.5%
Q1 FY2018Mar 31, 2018$25.25M-1.1%
Q4 FY2017Dec 31, 2017$27.75M+10.6%
Q3 FY2017Sep 30, 2017$24.75M+11.5%
Q2 FY2017Jun 30, 2017$23.91M–
Q1 FY2017Mar 31, 2017$25.53M–
Q4 FY2016Dec 31, 2016$25.08M–
Q3 FY2016Sep 30, 2016$22.19M–

More Standard BioTools figures

See a number that looks wrong?